Comparative Pathology of Proliferative Lesions of the Urinary Bladder

Bladder neoplasia in humans consists of 2 diseases, a low-grade papillary tumor that does not invade or metastasize, and a high-grade lesion that usually invades and metastasizes. Bladder carcinogenesis in rats is most like the low-grade, papillary tumor, although it eventually does progress and invade. In the mouse, models are available that mimic each of these disease processes. Preneoplastic lesions in humans and rodents include various types of hyperplasia, proliferative cystitis, and dysplasia. These preneoplastic and neoplastic lesions arise throughout the urothelium, from the renal pelvis to the urethra, although most commonly in the bladder. Rarely, benign and malignant mesenchymal lesions occur in rats and mice, with a unique submucosal mesenchymal lesion present in some strains of mice. In addition, eosinophilic and clear inclusions in the superfi cial layer of urothelium in mice, which do not appear to be associated with toxicity or carcinogenesis, have been reported. An approach to evaluation of carcinogenic mechanisms involved in the urothelium is presented. It focuses on distinguishing between DNA reactive carcinogens vs those that act by increasing cell proliferation. Although rodent model s do not precisely mimic the human disease, they have provided useful model s for furthering our understanding of the carcinogenic process in the urothelium as it pertains to human diseases.

[1]  A. Schauer,et al.  Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats , 2004, Zeitschrift für Krebsforschung und Klinische Onkologie.

[2]  M. Eldan,et al.  Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. , 1999, Carcinogenesis.

[3]  S. Cohen,et al.  Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. , 1999, IARC scientific publications.

[4]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[5]  M. Droller,et al.  Bladder cancer: State‐of‐the‐art care , 1998, CA: a cancer journal for clinicians.

[6]  R. Smith,et al.  Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential DNA adducts of o-phenylphenol in male rats. , 1998, Toxicology and applied pharmacology.

[7]  S. Cohen Cell Proliferation and Carcinogenesis , 1998 .

[8]  M. S. St John,et al.  Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine in B6D2F1 mice , 1998, Molecular carcinogenesis.

[9]  S. Cohen,et al.  Tributyl phosphate effects on urine and bladder epithelium in male Sprague-Dawley rats. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[10]  C. Cordon-Cardo,et al.  Genetic studies and molecular markers of bladder cancer. , 1997, Seminars in surgical oncology.

[11]  T. Sun,et al.  Analysis of differentiation-associated proteins in rat bladder carcinogenesis. , 1996, Carcinogenesis.

[12]  H. Gibb,et al.  Human bladder cancer: evidence for a potential irritation-induced mechanism. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[13]  S. Cohen,et al.  Role of urinary physiology and chemistry in bladder carcinogenesis. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  S. Cohen,et al.  Effects of stones and other physical factors on the induction of rodent bladder cancer. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  Urinary bladder carcinogenesis: implications for risk assessment. Rodent Bladder Carcinogenesis Working Group. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  S. Cohen,et al.  Mitogenic effects of propoxur on male rat bladder urothelium. , 1994, Carcinogenesis.

[17]  T. Shirai,et al.  p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. , 1994, Carcinogenesis.

[18]  T. Sun,et al.  Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. , 1994, The Journal of biological chemistry.

[19]  S. Cohen,et al.  p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. , 1994, Carcinogenesis.

[20]  R. Cote,et al.  Two molecular pathways to transitional cell carcinoma of the bladder. , 1994, Cancer research.

[21]  S. Cohen,et al.  Epidemiology and etiology of bladder cancer. , 1992, The Urologic clinics of North America.

[22]  L. Ellwein,et al.  Cell proliferation in carcinogenesis. , 1990, Science.

[23]  S. Cohen,et al.  Comparative analysis of the proliferative response of the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography. , 1990, Scanning microscopy.

[24]  L B Ellwein,et al.  The health risks of saccharin revisited. , 1990, Critical reviews in toxicology.

[25]  G. Steineck,et al.  Industry-related urothelial carcinogens: application of a job-exposure matrix to census data. , 1989, American journal of industrial medicine.

[26]  S. Cohen,et al.  Uracil-induced calculi and proliferative lesions of the mouse urinary bladder. , 1988, Carcinogenesis.

[27]  M. Hirose,et al.  Epithelial lesions of the urinary bladder in three hundred and thirteen autopsy cases. , 1987, Japanese journal of cancer research : Gann.

[28]  S. Cohen,et al.  Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion. , 1987, Cancer research.

[29]  U. Engelmann,et al.  Bladder carcinogenesis in portacaval shunt rats. , 1987, Urologia internationalis.

[30]  S. Fukushima,et al.  Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. , 1986, Cancer research.

[31]  S. Fukushima,et al.  Carcinogenesis, Urinary Tract, Rat , 1986 .

[32]  R. E. Greenfield,et al.  Urinary bladder carcinogenesis. , 1999, IARC scientific publications.

[33]  J. Robinson The lower urinary tract. , 1982, British journal of clinical pharmacology.

[34]  S. Cohen,et al.  Scanning electron microscopic examination of reversible hyperplasia of the rat urinary bladder. , 1981, The American journal of pathology.

[35]  M. Sporn,et al.  N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. , 1981, Cancer research.

[36]  S. Cohen,et al.  Scanning electron microscopy of cyclophosphamide-induced hyperplasia of the rat urinary bladder. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[37]  L. Koss,et al.  The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. , 1979, The Journal of urology.

[38]  Jull Jw The effect of time on the incidence of carcinomas obtained by the implantation of paraffin wax pellets into mouse bladder. , 1979 .

[39]  J. W. Jull The effect of time on the incidence of carcinomas obtained by the implantation of paraffin wax pellets into mouse bladder. , 1979, Cancer letters.

[40]  J. Jacobs,et al.  Chemically induced smooth muscle tumors of the mouse urinary bladder. , 1976, Cancer research.

[41]  Schistosomiasis and bladder cancer. , 1976, Medical journal of Zambia.